EFFECT OF PYRIDOSTIGMINE AND PIRENZEPINE ON GH RESPONSES TO GHRH IN HYPERTHYROID PATIENTS

被引:18
作者
VALCAVI, R
DIEGUEZ, C
ZINI, M
PAGE, MD
DOTTI, C
PORTIOLI, I
SCANLON, MF
机构
[1] FAC MED SANTIAGO DE COMPOSTELA,DEPT FISIOL,POB 563,SANTIAGO,SPAIN
[2] UNIV WALES COLL MED,DEPT MED,NEUROENDOCRINE UNIT,CARDIFF CF4 4XN,S GLAM,WALES
[3] ARCISPEDALE S MARIA NUOVA,DIV MED GEN 2,SEZ ENDOCRINO METAB,REGGIO EMILIA,ITALY
关键词
D O I
10.1111/j.1365-2265.1991.tb03512.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE We wished to investigate whether thyrotoxicosis can influence the cholinergic modulation of GH secretion. DESIGN Pyridostigmine was given orally, then GHRH injected i.v., and levels were measured. In a separate study, pirenzepine was injected i.v., then GHRH, and growth hormone levels were measured. PATIENTS Thyrotoxic patients were compared with normal subjects. MEASUREMENTS GH was measured from -30 to +120 minutes at intervals of 15 minutes. RESULTS Pyridostigmine markedly increased GH responses to GHRH in normal subjects, but not in thyrotoxic patients. Pirenzepine abolished the GH response to GHRH in thyrotoxic patients. CONCLUSIONS GH responses to GHRH in hyperthyroid patients were suppressed by cholinergic muscarinic receptor blockade with pirenzepine. Activation of cholinergic pathways with pyridostigmine did not increase GH responses to GHRH in these patients. This may be a consequence of increased hypothalamic cholinergic function or reduced hypothalamic GHRH activity in hyperthyroidism. Our findings demonstrate a further mechanism by means of which thyroid status may affect the secretory activity of the somatotroph.
引用
收藏
页码:141 / 144
页数:4
相关论文
共 22 条
[1]   DEVELOPMENT OF MARKERS FOR CHOLINERGIC NEURONS IN RE-AGGREGATE CULTURES OF FETAL-RAT WHOLE BRAIN IN SERUM-CONTAINING AND SERUM-FREE MEDIA - EFFECTS OF TRIIODOTHYRONINE (T-3) [J].
ATTERWILL, CK ;
KINGSBURY, A ;
NICHOLLS, J ;
PRINCE, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1984, 83 (01) :89-102
[2]   GROWTH HORMONE IN THYROTOXICOSIS - EFFECT OF INSULIN-INDUCED HYPOGLYCEMIA [J].
BURGESS, JA ;
SMITH, BR ;
MERIMEE, TJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1966, 26 (11) :1257-+
[3]   ATROPINE BLOCKADE OF GROWTH-HORMONE (GH)-RELEASING HORMONE-INDUCED GH SECRETION IN MAN IS NOT EXERTED AT PITUITARY LEVEL [J].
CASANUEVA, FF ;
VILLANUEVA, L ;
DIEGUEZ, C ;
CABRANES, JA ;
DIAZ, Y ;
SZOKE, B ;
SCANLON, MF ;
SCHALLY, AV ;
FERNANDEZCRUZ, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (01) :186-191
[4]   DOPAMINERGIC AND CHOLINERGIC INFLUENCES ON THE GROWTH-HORMONE RESPONSE TO GROWTH HORMONE-RELEASING HORMONE IN MAN [J].
DELITALA, G ;
PALERMO, M ;
ROSS, R ;
COY, D ;
BESSER, M ;
GROSSMAN, A .
NEUROENDOCRINOLOGY, 1987, 45 (03) :243-247
[5]  
DIEGUEZ C, 1988, CLIN ENDOCRINOL, V28, P109
[6]   THE EFFECTS OF THYROID-HORMONE DEPRIVATION INVIVO AND INVITRO ON GROWTH-HORMONE (GH) RESPONSES TO HUMAN PANCREATIC (TUMOR) GH-RELEASING FACTOR (1-40) BY DISPERSED RAT ANTERIOR-PITUITARY CELLS [J].
DIEGUEZ, C ;
FOORD, SM ;
PETERS, JR ;
HALL, R ;
SCANLON, MF .
ENDOCRINOLOGY, 1985, 116 (03) :1066-1070
[7]  
FINKELST.JW, 1974, J CLIN ENDOCR METAB, V38, P634, DOI 10.1210/jcem-38-4-634
[8]  
FROHMAN LA, 1986, ENDOCR REV, V7, P323
[9]  
JONES PM, 1990, ENDOCRINOLOGY, V126, P1384
[10]   INFLUENCE OF DOPAMINERGIC, ADRENERGIC AND CHOLINERGIC BLOCKADE AND TRH ADMINISTRATION ON GH-RESPONSES TO GRF 1-29 [J].
JORDAN, V ;
DIEGUEZ, C ;
LAFAFFIAN, I ;
RODRIGUEZARNAO, MD ;
GOMEZPAN, A ;
HALL, R ;
SCANLON, MF .
CLINICAL ENDOCRINOLOGY, 1986, 24 (03) :291-298